The first step in the journey from imprecise drug therapy to precision medicine – REPO4EU
BioLizard is proud to join the REPO4EU consortium.
BioLizard is now an Official Illumina Connected Analytics Implementation Partner
BioLizard is recognised as a skilled and competent service partner for ICA users.
BioLizard enters into a strategic partnership with flanders.bio
We’re proud to officially announce that BioLizard begins its strategic partnership with flanders.bio.
BioLizard partners up with AutoML provider JADBio
BioLizard partners with JADBio, a leading provider of automated machine learning (AutoML) tools.
BioLizard joins the at.las ATMP community
We’re proud to join the at.las ATMP community!
The future of clinical studies lies in decentralization
Our general manager, Liesbeth Ceelen, sits down with Joris Hendrickx from mediaplanet to discuss the future of clinical studies.
We are expanding our services in Switzerland
With the appointment of Per Rigler as Business Development Manager, we expand our business in Switzerland.
Artificial intelligence takes bioinformatics to the next level
BioLizard’s Liesbeth Ceelen and Wim Van Criekinge sit down with Joris Hendrickx from mediaplanet.
Development of blood multi-omic biomarkers for early colorectal cancer detection
Eurostars project in collaboration with Novigenix SA, Maastricht University and UZ Leuven.
Developing an AI-based diagnostic algorithm for early colon cancer detection
Together with Novigenix we will develop an AI-based clinical diagnostic algorithm for early colon cancer detection.
